Study Path Agent
Copy link
X / Twitter
Facebook
LinkedIn
WhatsApp
Generate Your Own
Myocardial infarction
84 topics across 7 chapters
Chapter 1
Epidemiology & risk factors
1
Epidemiology & burden (incidence, mortality, disparities)
2
Modifiable risk factors
4 subtopics
3
Lipids, hypertension & diabetes as MI risks: what to screen and target (conceptual)
4
Smoking cessation counseling & pharmacotherapy (NRT/varenicline/bupropion)
5
Diet, obesity & physical inactivity: cardiometabolic risk fundamentals
6
Substance use (cocaine/stimulants) and MI risk: key mechanisms and implications
7
Non-modifiable & genetic risk (age, sex, family history, inherited dyslipidemias)
8
Prevention & risk communication (absolute risk, shared decision-making basics)
Chapter 2
Anatomy & pathophysiology
9
Coronary anatomy & myocardial territories
2 subtopics
10
Coronary dominance & key branches (LAD/LCx/RCA)
11
Territories and MI localization (anatomy ↔ ECG concept map)
12
Type 1 MI pathogenesis (plaque rupture/erosion → thrombosis)
13
Type 2 MI pathogenesis (supply–demand mismatch)
14
Infarct evolution & remodeling
3 subtopics
15
Time course of ischemic injury (reversible vs irreversible injury)
16
Reperfusion injury, stunning & no-reflow (conceptual)
17
Ventricular remodeling, scar & aneurysm formation (conceptual)
Chapter 3
Presentation & initial assessment
18
Typical presentation & physical exam clues
19
Atypical/silent presentations (women, elderly, diabetes)
20
Differential diagnosis of chest pain (PE, dissection, pericarditis, pneumothorax, esophageal causes, etc.)
21
Initial stabilization & triage
3 subtopics
22
First 10 minutes checklist (ABCs, monitoring, IV access, targeted oxygen, glucose, analgesia approach)
23
Serial ECGs and when to activate a STEMI pathway
24
Workup of the unstable patient (bedside echo/POCUS, CXR, basic labs)
Chapter 4
Diagnosis & classification
25
ECG interpretation for MI
3 subtopics
26
STEMI criteria & STEMI equivalents (posterior, RV, de Winter, etc.)
27
NSTEMI/ischemia patterns (ST depression, T inversion)
28
ECG pitfalls (LBBB/paced rhythms, pericarditis, early repolarization, hyperkalemia)
29
Troponin & biomarkers
3 subtopics
30
High-sensitivity troponin principles (99th percentile, delta change, timing)
31
Rule-in/rule-out pathways (0/1h, 0/2h, 0/3h concepts)
32
Non-ischemic causes of troponin elevation (myocarditis, CKD, PE, sepsis, tachyarrhythmia, etc.)
33
Imaging in suspected MI (echo/CT/MRI): when and why
34
MI definitions & classification (STEMI/NSTEMI, type 1/2, MINOCA)
35
Risk stratification & disposition (TIMI/GRACE/Killip concepts)
Chapter 5
Acute management
36
Antithrombotic therapy
3 subtopics
37
Aspirin + P2Y12 selection and timing (conceptual)
38
Anticoagulants (UFH/LMWH/bivalirudin): indications & basics (conceptual)
39
Bleeding risk, contraindications, and peri-procedural management (conceptual)
40
Reperfusion & invasive strategy
3 subtopics
41
Primary PCI workflow and timing metrics (conceptual)
42
Fibrinolysis: indications, contraindications, complications (conceptual)
43
NSTEMI: early invasive vs ischemia-guided approach (conceptual)
44
Adjunct acute medications (nitrates, beta-blockers, statins, ACEi/ARB; analgesia/antiemetics; oxygen strategy)
45
Cardiogenic shock & cardiac arrest
3 subtopics
46
Initial cardiogenic shock management (hemodynamics, vasopressors/inotropes concepts, early cath)
47
Mechanical circulatory support overview (IABP/Impella/VA-ECMO): indications & tradeoffs (conceptual)
48
Post–cardiac arrest care in suspected MI (TTM concepts, cath lab decisions)
49
Systems of care (STEMI activation, transfers, door-to-balloon / door-to-needle concepts)
Chapter 6
Complications & inpatient course
50
Arrhythmias after MI
3 subtopics
51
VT/VF recognition and defibrillation fundamentals
52
Bradyarrhythmias/AV block and pacing approach (conceptual)
53
Atrial fibrillation after MI: rate/rhythm control & anticoag considerations (conceptual)
54
Mechanical complications
4 subtopics
55
Papillary muscle rupture & acute mitral regurgitation: recognition and urgent steps (conceptual)
56
Ventricular septal rupture: recognition and urgent steps (conceptual)
57
Free-wall rupture & tamponade: recognition and urgent steps (conceptual)
58
Pseudoaneurysm vs true aneurysm: key distinctions (conceptual)
59
Heart failure & thromboembolism
3 subtopics
60
Acute heart failure/pulmonary edema management after MI (conceptual)
61
LV thrombus detection and anticoagulation basics (conceptual)
62
Right ventricular infarct recognition and management (preload, nitrates caution)
63
Pericarditis & post-MI inflammatory syndromes (early pericarditis, Dressler)
Chapter 7
Secondary prevention & rehabilitation
64
Discharge planning
2 subtopics
65
Discharge checklist (meds, EF, cardiac rehab referral, follow-up timing)
66
Patient education: red flags, medication reconciliation, and an action plan
67
Secondary prevention medications
4 subtopics
68
Antiplatelet strategy after MI (DAPT duration, de-escalation concepts)
69
Lipid lowering intensification (ezetimibe/PCSK9 concepts, LDL targets and monitoring)
70
Beta-blocker + RAAS/MRA therapy: who benefits and for how long (conceptual)
71
Vaccination & inflammation-modifying therapies (flu shot; colchicine concepts)
72
Lifestyle & cardiac rehabilitation
3 subtopics
73
Exercise prescription & rehab phases (early mobilization → supervised rehab → maintenance)
74
Diet/weight/BP goals & cardiometabolic risk (practical targets and tracking)
↗
Smoking cessation counseling & pharmacotherapy (NRT/varenicline/bupropion)
(see Chapter 1)
75
Long-term follow-up (EF reassessment, ICD/WCD concepts, return to work/driving/sex)
76
Psychosocial, adherence & health equity (depression screening, cost barriers, support systems)